Thomas Braxton King, President & CEO at Alexza Pharmaceuticals Inc. (ALXA), sold 12,500 shares at $7.20 ($90K) on 2007-11-09, disclosed to the SEC on 2007-11-13.
Scheduled sale ($90k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ALXA | SELL | 2012-08-29 | $41K | — | Filing → |
| ALXA | SELL | 2012-06-08 | $22K | — | Filing → |
| ALXA | SELL | 2009-12-21 | $100K | — | Filing → |